The latest news about global vaccine research and development shows that we have made great progress in vaccine development. However, in China, a large population of people are hesitant to get vaccinated due to various reasons. In this article, we focus on how to address people's hesitancy on the coronavirus disease 2019 (COVID-19) vaccine. It is important that governments fully prepare for both pre-risk prevention and post-event relief to promote the vaccination program's smooth implementation. In particular, the government should establish and improve a national vaccine injury compensation program in response to COVID-19's adverse events following immunization. Only through multilateral efforts and comprehensive measures can the people's confidence in vaccination improve and their worries about the future be relatively eased.
Addressing People's Vaccine Hesitancy Will Be Helpful for COVID-19 Vaccination in China